RSS   Newsletter   Contact   Advertise with us
Post Online Media

Hologic appoints Amy Wendell to board

HologicHologic, a developer of diagnostic products, announced that Amy Wendell has been elected to the company's board of directors.
Article continues below

READ MORE AxoGen appoints Amy Wendell to board of directors

Ms. Wendell also was appointed to the Company's Audit and Finance Committee.

Ms. Wendell brings to Hologic a wealth of experience in the healthcare industry, particularly in the areas of market and technology development.

As Senior Vice President of Strategy and Business Development for Covidien plc, until it was acquired by Medtronic in 2015, Ms. Wendell led strategic planning and portfolio management, as well as all business development initiatives including mergers and acquisitions, integrations, equity investments, divestitures, licensing, distribution and market intelligence.

Ms. Wendell is also a Director of Ekso Bionics, and AxoGen, Inc..

She received a bachelor's degree from Lawrence Technological University (Mich.) and a master's degree in biomedical engineering from the University of Illinois.

 LATEST MOVES FROM Massachusetts 


We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy